By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ironwood Pharmaceuticals 

301 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-621-7722 Fax: 617-494-0480


Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our team to passionately pursue excellence. We discovered, developed and are commercializing linaclotide, which is approved in the United States and a number of other countries. Our pipeline priorities include exploring further opportunities for linaclotide, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at or on Twitter at

Key Statistics

Ownership: Public

Web Site: Ironwood
Symbol: IRWD


Company News
Vertex (VRTX) Poaches New CFO From Ironwood (IRWD) 9/6/2017 6:40:16 AM
Ironwood (IRWD) To Present At Upcoming September Investor Conferences 9/1/2017 7:11:04 AM
Ironwood (IRWD) Announces FDA Approval Of DUZALLO (Lesinurad And Allopurinol) For The Treatment Of Hyperuricemia In Patients With Uncontrolled Gout 8/21/2017 7:28:11 AM
Ironwood (IRWD) Provides Second Quarter 2017 Investor Update 8/4/2017 8:13:05 AM
Data Put A Dent In Ironwood (IRWD)'s Expansion Plans 7/24/2017 6:46:21 AM
Ironwood (IRWD) To Host Second Quarter 2017 Investor Update Call 7/21/2017 7:49:57 AM
Ironwood (IRWD)'s Potential Blockbuster Drug Meets Main Goals in Mid-Stage Trial 7/20/2017 7:28:10 AM
Ironwood (IRWD) Presents Data Further Elucidating Linaclotide’s Effect On Pain At Digestive Disease Week 2017 5/10/2017 7:09:40 AM
Ironwood (IRWD) Provides First Quarter 2017 Investor Update 5/8/2017 7:51:57 AM
Ironwood (IRWD) To Present New Data For Linaclotide, Linaclotide Delayed Release And IW-1701 At Digestive Disease Week 2017 5/1/2017 6:00:17 AM